Skip over navigation
Directory
Directory Search
Jobs
Job Search
Post a Job
Patient
Patient Resources
Drug Development
History
Genealogy
Toons & Teasers
About
Advertising
Home
Quick Links
Directory
Job Search
Toons & Teasers
Advertising
LifeScienceHistory.com - Check us out on Instagram
Take Your Next Career Step with Lundback
Industry News
Search Articles:
AstraZeneca and Merck’s LYNPARZA® (olaparib) approved in Japan for BRCAm ovarian cancer
AstraZeneca and Merck announced that Japan’s Pharmaceuticals and Medical Devices Agency (PMDA) has approved LYNPARZA as a maintenance treatment after first-line chemotherapy in patients with BRCA-mutated ovarian cancer.
June 19, 2019
More...
Email This Page
to a Friend
Print This
Page